Sono-Hepatic-Arteriography (Sono-HA) in the Assessment of Hepatocellular Carcinoma in Patients Undergoing Transcatheter Arterial Chemoembolization (TACE)

Zusammenfassung

Ziel: Ziel der Studie war die Evaluation der Sonoarterioportografie in der Detektion fokaler Leberraumforderungen bei Patienten mit hepatozellulärem Karzinom, die sich einer transarteriellen Chemoembolisation unterzogen haben. Material und Methoden: Von Februar 2006 bis Mai 2008 wurden 15 Patienten mit HCC, die sich einer transarteriellen Chemoembolisation unterzogen haben, in die Studie eingeschlossen. Zunächst erfolgte bei allen Patienten eine B-Bild-Sonografie mit einem High-End-Gerät und einem Multifrequenzschallkopf (2,5 – 4 MHz). Im Anschluss daran wurde eine Kontrastmittelsonografie mit Contrast Harmonic Imaging durchgeführt. Für die Sonoarterioportografie wurde 1 ml SonoVue® als Bolus injiziert. Hierzu wurde der bereits liegende intraarterielle Katheter genutzt. Eine 16-Zeilen-Computertomografie wurde spätestens 48 Stunden vor der Chemoembolisation durchgeführt, außerdem im Rahmen der Nachsorgeuntersuchungen. Ergebnisse: Die Größe der Läsionen betrug 1 – 13 cm im größten Durchmesser (Mittelwert: 4,8 cm). In 8 Fällen diagnostizierte die i. v.-Kontrastmittelsonografie mehr Läsionen als die B-Bild-Sonografie und in 5 Fällen mehr Raumforderungen als die Computertomografie. Die Ergebnisse der Sonoarterioportografie waren in 14 Fällen (93,3 %) korrekt. Dies hatte bei 11 Patienten (73,3 %) unmittelbare Auswirkung auf das weitere Procedere. Schlussfolgerung: Wir konnten zeigen, dass die Applikation eines intraarteriellen Kontrastmittels während der Chemoembolisation dazu beiträgt neue Läsionen zu diagnostizieren und den Erfolg der transarteriellen Chemoembolisation unmittelbar beurteilen zu können. Dies kann die Ergebnisse der transarteriellen Chemoembolisation und das Outcome des Patienten verbessern.

Abstract

Purpose: The aim of our study was to evaluate sono-hepatic-arteriography in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization. Materials and Methods: We evaluated 15 patients with hepatocellular carcinoma undergoing TACE who presented in our institution from February 2006 to May 2008. All patients underwent a conventional B-mode ultrasound examination using a high-end machine and a multi-frequency transducer (2.5 – 4 MHz) before dynamic contrast-enhanced ultrasound examination was carried out. For the sono-hepatic-arteriography 1 ml SonoVue® was injected as a bolus using the formerly placed intraarterial catheter. Biphasic enhanced computed tomography was performed using a 16-slice CT scanner up to 48 hours before transcatheter arterial chemoembolization and during follow-up. Results: The lesion size (of the largest lesion) ranged from 1 to 13 centimeters in their largest diameter (mean: 4.8 cm). Contrast-enhanced ultrasound diagnosed more lesions than B-mode sonography in eight cases and more lesions than computed tomography in 5 patients. The findings of sono-hepatic-arteriography were correct in fourteen cases (93.3 %). Direct impact on patient management was seen in eleven patients (73.3 %). Conclusion: We were able to show that the application of an intraarterial sonographic contrast agent during embolization is able to diagnose new lesions on the one hand and to assess the embolization success on the other. This might improve transcatheter arterial chemoembolization results and patient outcome.

chemoembolization - ultrasound - tumor

References

• 1 Bosch F X, Ribes J, Diaz M. et al . Primary liver cancer, worldwide incidence and trends.  Gastroenterology. 2004;  127 5-16
• 2 Forner A, Hessheimer A J, Real I M. et al . Treatment of hepatocellular carcinoma.  Critical Rev Oncol Hematol. 2006;  60 89-98
• 3 Schmidt J, Strotzer M, Fraunhofer S. et al . Intraoperative ultrasonography versus helical computed tomography and computed tomography with arterioportography in diagnosing colorectal liver metastases: lesion-by-lesion analysis.  World J Surg. 2000;  24 43-47
• 4 Strotzer M, Gmeinwieser J, Schmidt J. et al . Diagnosis of liver metastases from colorectal adenocarcinoma. Comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plain MR imaging.  Acta Radiol. 1997;  38 986-992
• 5 Conlon R, Jacobs M, Dasgupta D. et al . The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging.  Eur J Ultrasound. 2003;  16 211-216
• 6 Mazzaferro V, Battiston C, Perrone S. et al . Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study.  Ann Surg. 2004;  240 900-909
• 7 Rode A, Bancel B, Douek P. et al . Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver.  J Comput Assist Tomogr. 2001;  25 327-336
• 8 Libbrecht L, Bielen D, Verslype C. et al . Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations.  Liver Transp. 2002;  8 749-761
• 9 Ledinghen de V, Laharie D, Lecesne R. et al . Detection of nodules in liver cirrhosis: spiral computed tomograpy or magnetic resonance imaging? A prospective study of 88 nodules in 34 patients.  Eur J Gastroenterol Hepatol. 2002;  14 159-165
• 10 Kim Y K, Kwak H S, Kim C S. et al . Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT.  Radiology. 2006;  238 531-541
• 11 Kato H, Kanematsu M, Kondo H. et al . Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic tumor grade and tumor vascularity.  J Magn Reson Imaging. 2004;  19 76-81
• 12 Barthia B, Ward J, Guthrie J A. et al . Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue.  Am J Roentgenol. 2003;  180 577-584
• 13 Kim S R, Ando K, Mita K. et al . Superiority of CT arterioportal angiography to contrast-enhanced CT and MRI in the diagnosis of hepatocellular carcinoma in nodules smaller than 2 cm.  Oncology. 2007;  72 58-66
• 14 Tsurusaki M, Sugimoto K, Fujii M. et al . Combination of CT during arterial portography and double-phase CT hepatic arteriography with multi-detector row helical CT for evaluation of hypervascular hepatocellular carcinoma.  Clin Radiol. 2007;  62 1189-1197
• 15 Larson A C, Wang D, Atassi B. et al . Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma: feasibility of initial clinical translation.  Radiology. 2008;  246 964-971
• 16 Peterson M S, Baron R L. Radiologic diagnosis of hepatocellular carcinoma.  Clin Liver Dis. 2001;  5 123-144
• 17 Liu W C, Lim J H, Park C K. et al . Poor sensitivity of sonography in detection of hepatocellular carcinoma in advanced liver cirrhosis: accuracy of pretransplantation sonography in 118 patients.  Eur Radiol. 2003;  13 1693-1698
• 18 Rickes S, Schulze S, Neye H. et al . Improved diagnosing of small hepatocellular carcinomas by echo-enhanced power Doppler sonography in patients with cirrhosis.  Eur J Gastroenterol Hepatol. 2003;  15 893-900
• 19 Tanaka S, Ioka T, Oshikawa O. et al . Dynamic sonography of hepatic tumors.  Am J Roentgenol. 2001;  177 799-805
• 20 Gaiani S, Celli N, Piscaglia F. et al . Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography.  J Hepatol. 2004;  41 421-426
• 21 Quaida E, Calliada F, Bertolotto M. et al . Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.  Radiology. 2004;  232 420-430
• 22 Jung E M, Clevert D A, Schreyer A G. et al . Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: A prospective controlled two-center study.  World J Gastroenterol. 2007;  13 6356-6364
• 23 Claudon M, Cosgrove D, Albrecht T. et al . Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) – update 2008.  Ultraschall in Med. 2008;  29 28-44
• 24 Herbay von A, Haeussinger D, Gregor M. et al . Characterization and detection of hepatocellular carcinoma (HCC): comparison of the ultrasound contras agents SonoVue (BR 1) and Levovist (SHU 508A) – comparison of SonoVue and Levovist in HCC.  Ultraschall in Med. 2007;  28 168-175
• 25 Rickes S, Ocran K, Schulze S. et al . Evaluation of Doppler sonographic criteria for the differentiation of hepatocellular carcinomas and regenerative nodules in patients with liver cirrhosis.  Ultraschall in Med. 2002;  23 83-90
• 26 Kumada T, Nakano S, Takeda I. et al . Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis.  Journal of hepatology. 1999;  30 125-130
• 27 Bruix J, Sherman M. AASLD Practice Guideline: Management of hepatocellular carcinoma.  Hepatology. 2005;  42 1208-1236
• 28 Cormier J N, Thomas K T, Chari R S. et al . Management of hepatocellular carcinoma.  J Gastrointest Surg. 2006;  10 761-780
• 29 Llado L, Virgili J, Figueras J. et al . A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoemboliztion.  Cancer. 2000;  88 50-57
• 30 Yamasaki T, Matsukawa T, Arakawa A. et al . US-guided liver biopsy: predicting the effect of interventional treatment of hepatocellular carcinoma.  Radiology. 1995;  196 799-804
• 31 Ito K, Honjo K, Fujita T. et al . Therapeutic efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma: MRI and pathology.  J Comput Assist Tomogr. 1995;  19 198-203
• 32 Zhao J G, Feng G S, Kong X Q. et al . Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging.  World J Gastroenterol. 2004;  10 1152-1156
• 33 Kono Y, Lucidarme O, Choi S H. et al . Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma.  J Vasc Interv Radiol. 2007;  18 57-65
• 34 Numata K, Morimoto M, Ogura T. et al . Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography.  J Ultrasound Med. 2008;  27 395-406